KEVIN O'SHEA: Open Payments
NPI 1942391750 · JENKINTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,875 in 102 payments from 19 companies in 2025. Trend: 2023 $2,617 · 2024 $2,968 · 2025 $1,875
Food & beverage: $1,875
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 37 | $561 |
| Novartis Pharmaceuticals Corporation | 9 | $250 |
| ABBVIE INC. | 15 | $190 |
| Incyte Corporation | 5 | $143 |
| E.R. Squibb & Sons, L.L.C. | 6 | $112 |
| GENZYME CORPORATION | 3 | $79 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $76 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $60 |
| PFIZER INC. | 3 | $54 |
Products named: TREMFYA, COSENTYX, OPZELURA, Sotyktu, DUPIXENT, RINVOQ, SKYRIZI, Cabtreo.
Industry payments across PA — which companies pay providers there.
